Integral Molecular Secures Nearly $900K In Nih Funding To Discover Antibodies Against Difficult And Conserved Protein Targets
Amount Raised
$900,000
Round Type
Seed
PhiladelphiaBiotechnologyInvestors
Description
Integral Molecular, a leading biotech company specializing in antibody discovery against challenging protein targets, announces that it has been awarded NIH funding totaling $896,000. The NIH has identified 230 GPCRs and ion channels as underexplored targets with potential to impact human health as part of its project, Illuminating the Druggable Genome. Funding awarded by NIH enables Integral Molecular to discover antibodies against many of these targets. To enable better models of human disease, Integral Molecular has also received NIH funding to discover antibodies that target highly conserved proteins across species.
Quick answer
Integral Molecular raised $900,000 in a Seed round, dated October 5, 2023. Investors: Nih. Integral Molecular is based in Philadelphia, Pennsylvania, United States.
- How much did Integral Molecular raise?
- Integral Molecular raised $900,000 in a Seed round on October 5, 2023.
- Who invested in Integral Molecular?
- Nih is named as investors in this round.
- What does Integral Molecular do?
- Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies for under-exploited membrane protein targets, including GPCRs, ion channels, and..
- Where is Integral Molecular based and how big is it?
- Integral Molecular is based in Philadelphia, Pennsylvania, United States. Fundz records about 130 employees.
- Who are the decision-makers at Integral Molecular?
- Fundz holds 2 contacts at Integral Molecular, including the VP Sales and Customer Relations. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Integral Molecular that raised within 45 days of this round, from Fundz verified event records.
- Seismic Therapeutic raised $146M on November 17, 2023.
- Greenbrook TMS raised $2.5M (Seed) on November 16, 2023.
- Proxima Fusion raised an undisclosed amount (Pre-Seed) on November 16, 2023.
- Nature's Toolbox raised $48M (Series B) on November 16, 2023.
- Route 92 Medical raised $31M (Series F) on November 16, 2023.
- On Target Laboratories raised $30M (Funding Round) on November 16, 2023.
Who to call at Integral Molecular, and when
A new round usually means Integral Molecular is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Integral Molecular raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Integral Molecular, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Integral Molecular. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Integral Molecular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Integral Molecular raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.